Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: A study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material

British Journal of Cancer

Volumn 76, Issue 1, 1997, Pages 54-59

  Linder, S ^a   Parrado, C ^b   Falkmer, U G ^b   Blasjo M ^a   Sundelin, P ^a   Von Rosen, A ^c  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Immunohistochemistry; Ki 67 antigen; p53; Pancreatic carcinoma; Prognosis

Indexed keywords

FORMALDEHYDE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KI 67; PARAFFIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE FIXATION;

EID: 0031011616     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.336     Document Type: Article

References (26)

1. Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Klöppel G, Theis B, Russel RCG, Neoptolemos J, Williamson RCN, Lane DP and Lemoine NR (1991) Abnormalities of the p53 tumour suppressor gene in human panereatic cancer. Br. J Cancer 64: 1076-1082
2. Baas IO, Van Den Berg FM, Mulder J-WR, Clement MJ, Slebos RJC, Hamilton SR and Offerhaus GJA (1996) Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorcetal neoplasms. J Pathol 178: 264-267
3. Van Den Berg FM, Baas IO, Polak MM and Offerhaus GJA (1993) Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol 142: 381-385
4. Berrozpe G, Schaeffer J, Peinado MA, Real FX and Perucho M (1994) Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer, Int J Cancer 58: 185-191
5. Bodner SM, Minna JD, Jensen SM, D'Amico D, Carbone D, Mitsudomi T, Fedorko J, Buchhagen DL, Nau MM, Gazdar AF and Linnoila RI (1992) Expression of mutant P53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7: 743-749
6. Digiuseppe JA, Hruban RH, Goodman SN, Polak M, Van Den Berg FM, Allison DC, Cameron JL and Offerahaus JA (1994) Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 101: 684-688
7. Hamelin R, Laurent-Puig P, Olschwang S, Jege N, Asselain B, Remvikos Y, Girodet J, Salomon RJ and Thomas G (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106: 42-48
8. Hermanek P and Sobin LH (1987) UICC International Union Against Cancer. TNM Classification of Malignant Tumors, 4th fully revised edn. Springer-Verlag: Berlin
9. Isola J, Visakorpi T, Holli K and Kallioniemi OP (1992) Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84: 1109-1114
10. Kalthoff H, Schimegel W, Roeder C, Kasche D, Schmidt A, Lauer G, Thiele H-G, Honold G, Pantel K, Riethmüller G, Scherer E. Maurer J, Maacke H and Deppert W (1993) p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene 8: 289-298
11. Kelleher L, Magee HM and Dervan PA (1994) Evaluation of cell-proliferation antibodies reactive in paraffin sections. Appl Immunohistochem 2: 164-170
12. Lam K-Y, Law S Y-K, So M K-P, Fok M, Ma LT and Wong J (1996) Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma. Cancer 77: 7-12
13. Linder S, Lindholm J, Falkmer U, Bläsjö M, Sundelin P and Von Rosen A (1995) Combined use of nuclear morphometry and DNA ploidy as prognostic indicators in nonresectable adenocarcinoma of the pancreas. Int J Pancreatol 18: 241-248
14. Lundin J, Nordling S, Von Boguslawsky K, Roberts PJ and Haglund C (1995) Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer. Anticancer Res 15: 2659-2668
15. Lundin J, Nordling S, Von Boguslawski K, Roberts PJ and Haglund C (1996) Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer. Oncology 53: 104-111
16. Martin HM, Filipe MI, Morris RW, Lane DP and Silvestre F (1992) p53 expression and prognosis in gastric carcinoma. Int J Cancer 50: 859-862
17. McCormick D, Chong H, Hobbs C, Datta C and Hall PA (1993) Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 22: 355-360
18. Mørkve O, Halvorsen OJ, Stagenland L, Gulsvik A and Laerum OD (1992) Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA-ploidy) by multiparameter flow cytometry in non-small-cell lung cancer. Int J Cancer 52: 851-855
19. Parrado C, Falkmer UG, Höög A, Falkmer S, Ahrens O, Rius F and Grimelius L (1996) A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumours. A methodological study on the zKi-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry. Gen Diagn Pathol 141: 215-227
20. Pellegata NS, Sessa F, Renault B, Bonato M, Leone BE, Solcia E and Ranzani GN (1994) K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 54: 1556-1560
21. Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, Robertson JFR. Blamey RW and Ellis IO (1995) Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 71: 146-149
22. Railo M, Nordling S, Von Boguslawsky K, Leivonen M, Kyllönen L and Von Smitten K (1993) Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 68: 579-583
23. Ruggeri B, Zhang SY, Caamano J, Dirado M, Flynn SD and Klein-Szanto AJP (1992) Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Oncogene 7: 1503-1511
24. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C and Hirohashi S (1993) Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142: 1534-1543
25. Thompson SJ, Mellon K, Charlton RG, Marsh C, Robinson M and Neal DE (1992) P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia. Hr J Urol 69: 609-613
26. Weidner N, Moore DH and Vartanian R (1994) Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel 'paraffin'-reactive MIB1 antibody. Hum Pathol 25: 337-342